Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge.
about
Molecular Mechanisms of Cutaneous Inflammatory Disorder: Atopic DermatitisInterleukin-31 pathway and its role in atopic dermatitis: a systematic review.Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in miceIL-31 is overexpressed in lichen planus but its level does not correlate with pruritus severity.IL-31-Driven Skin Remodeling Involves Epidermal Cell Proliferation and Thickening That Lead to Impaired Skin-Barrier FunctionMonoclonal antibodies: the new magic bullets for allergy: IUPHAR Review 17.Update on skin allergy.The contribution of biotechnology toward progress in diagnosis, management, and treatment of allergic diseases.Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?Development and validation of the mastocytosis quality of life questionnaire: MC-QoL.Control of the Physical and Antimicrobial Skin Barrier by an IL-31-IL-1 Signaling Network.Mutual upregulation of endothelin-1 and IL-25 in atopic dermatitis.Analysis of the IL-31 pathway in Mycosis fungoides and Sézary syndrome.Peripheral Mechanisms of ItchEmerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis.Inflammatory and Noninflammatory Itch: Implications in Pathophysiology-Directed Treatments.The Future of Atopic Dermatitis Treatment.The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placNew therapies for controlling atopic itch.Immediate-type allergic and protease-mediated reactions are involved in scratching behaviour induced by topical application of Dermatophagoides farinae extract in NC/Nga mice.Cynomolgus monkey model of interleukin-31-induced scratching depicts blockade of human interleukin-31 receptor A by a humanized monoclonal antibody.Mast cell-neural interactions contribute to pain and itch.Interleukin (IL) 31 induces in cynomolgus monkeys a rapid and intense itch response that can be inhibited by an IL-31 neutralizing antibody.Is targeting interleukin-31 a cure for the itch? Lessons from amyloidosis.Skin provocation tests may help to diagnose atopic dermatitis.Interleukin-31, Interleukin-31RA, and OSMR Expression Levels in Post-burn Hypertrophic Scars
P2860
Q26739986-A694878A-429D-4696-879C-848754CB49E3Q34550406-AF79F030-D1F5-4998-B6AB-BCCF07FD9213Q34619451-A072913B-D7D6-4917-A436-FAE15A53ED8DQ35097815-CB9D6AE3-34C4-42A4-BE76-0246B04415C7Q36111385-A6FD7E78-6F18-4611-9F01-754B88D55563Q36599623-BD7C1404-445C-4196-BBC3-1904CE269534Q38256777-25A7D0EB-9446-41C1-8C06-9C4663CB492FQ38259275-218159A1-B782-4BC5-809F-A11FF41904A2Q38452688-51A595EB-4317-40E9-BE8A-017A4E876F75Q38707373-E5D1CBB9-FA84-4F2B-BF37-22D43E269739Q38788790-B2BD6482-4696-4E98-AEF4-1D5D15356F42Q38883416-F5161630-03B0-4B4D-A8D9-5EA55E9F62DFQ38930782-CAB8039D-8067-49F6-A1EC-D604A583AF63Q38941779-E18A9A03-D373-4549-A90D-19BADE8873F0Q39410617-4C14137B-806F-4BD4-B945-FFA59DC5F2DCQ39429573-E0BF35D9-4CDE-45FC-8366-FDAF63C993D2Q47880524-87E2AEA2-C81E-41E7-86BF-CE67CAAC26D3Q47933206-847FFA16-37D0-4B8C-803B-DB29C34694E0Q47941158-8EF905CC-B6DD-4B36-AB00-C98E5482F9D8Q48248430-14CA89C0-156D-4270-B9BB-31B43D90DFA7Q48316232-9438EE1A-49BB-45B7-A473-E7C1C3988AA5Q50068940-5B4D7E7D-690C-49F4-9477-385B771AB6EBQ51211550-A7C61D95-3F87-438D-9467-5527369A452AQ51696680-F80124CF-229F-4FFA-9555-0A021CC0D4D0Q53059424-CACDAB0A-6C55-4AFB-A90F-64F1AB6FF174Q58772430-3B29C1BE-22F6-4499-986A-BA54FF3B7904
P2860
Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Interleukin-31 does not induce ...... controls after skin challenge.
@en
Interleukin-31 does not induce ...... controls after skin challenge.
@nl
type
label
Interleukin-31 does not induce ...... controls after skin challenge.
@en
Interleukin-31 does not induce ...... controls after skin challenge.
@nl
prefLabel
Interleukin-31 does not induce ...... controls after skin challenge.
@en
Interleukin-31 does not induce ...... controls after skin challenge.
@nl
P2093
P2860
P50
P356
P1433
P1476
Interleukin-31 does not induce ...... controls after skin challenge
@en
P2093
P2860
P304
P356
10.1111/ALL.12316
P577
2013-11-20T00:00:00Z